Evidence map›Paper›PMID 31357938›Full record

ArticleBMC medical research methodology2019

Using marginal standardisation to estimate relative risk without dichotomising continuous outcomes.

Ying Chen, Yilin Ning, Shih Ling Kao, Nathalie C Støer, Falk Müller-Riemenschneider, Kavita Venkataraman, Eric Yin Hao Khoo, E-Shyong Tai, Chuen Seng Tan

Open access · goldAbstract read
In one paragraph

Article in BMC medical research methodology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Ying ChenSaw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
Yilin NingNUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore, Singapore.
Shih Ling KaoDepartment of Medicine, National University Hospital, Singapore, Singapore.
Nathalie C StøerNorwegian National Advisory Unit on Women's Health, Oslo University Hospital, Oslo, Norway.
Falk Müller-RiemenschneiderSaw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
Kavita VenkataramanSaw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
Eric Yin Hao KhooDepartment of Medicine, National University Hospital, Singapore, Singapore.
E-Shyong TaiDepartment of Medicine, National University Hospital, Singapore, Singapore.
Chuen Seng TanSaw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore. ephtcs@nus.edu.sg.
National University Health System · SGNational University of Singapore · SGNational University Hospital · SGOslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough criticisms regarding the dichotomisation of continuous variables are well known, applying logit model to dichotomised outcomes is the convention because the odds ratios are easily obtained and they approximate the relative risks (RRs) for rare events.

methodsTo avoid dichotomisation when estimating RR, the marginal standardisation method that transforms estimates from logit or probit model to RR estimate is extended to include estimates from linear model in the transformation. We conducted a simulation study to compare the statistical properties of the estimates from: (i) marginal standardisation method between models for continuous (i.e., linear model) and dichotomised outcomes (i.e., logit or probit model), and (ii) marginal standardisation method and distributional approach (i.e., marginal mean method) applied to linear model. We also compared the diagnostic test for probit, logit and linear models. For the real dataset analysis, we applied these analytical approaches to assess the management of inpatient hyperglycaemia in a pilot intervention study.

resultsAlthough the RR estimates from the marginal standardisation method were generally unbiased for all models in the simulation study, the marginal standardisation method for linear model provided estimates with higher precision and power than logit or probit model, especially when the baseline risks were at the extremes. When comparing approaches that avoid dichotomisation, RR estimates from these approaches had comparable performance. Assessing the assumption of error distribution was less powerful for logit or probit model via link test when compared with diagnostic test for linear model. After accounting for multiple thresholds representing varying levels of severity in hyperglycaemia, marginal standardisation method for linear model provided stronger evidence of reduced hyperglycaemia risk after intervention in the real dataset analysis although the RR estimates were similar across various approaches.

conclusionsWhen compared with approaches that do not avoid dichotomisation, the RR estimated from linear model is more precise and powerful, and the diagnostic test from linear model is more powerful in detecting mis-specified error distributional assumption than the diagnostic test from logit or probit model. Our work describes and assesses the methods available to analyse data involving studies of continuous outcomes with binary representations.

Indexed as

Linear ModelsLogistic ModelsResearch DesignComputer SimulationData Interpretation, StatisticalDatasets as TopicHumansHyperglycemiaInpatientsRisk AssessmentDichotomisationHyperglycaemiaLinear modelsLogistic modelsOdds ratioRelative risk

Identifiers

PMID31357938
PMCPMC6664591
OpenAlexW2964648066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.